netFormulary
 Report : A-Z NHS England items in Formulary 19/11/2018 22:12:02
[Back]
 
Section Status NHS England Name
11.04.02 Restricted Use MHS England Adalimumab Humira
13.05.03 Formulary MHS England Adalimumab Humira
08.01.05 Formulary MHS England Afatinib Giotrif
08.01.05 Formulary MHS England Alectinib Alecensa
08.02.04 Formulary MHS England Alemtuzumab Lemtrada
05.02.03 Restricted Use MHS England Amphotericin  Fungizone
05.02.03 Formulary MHS England Amphotericin Liposomal AmBisome
10.01.03 Restricted Use MHS England Anakinra Kineret
05.02.04 Formulary MHS England Anidulafungin Ecalta
08.02.02 Formulary MHS England Antithymocyte immunoglobulin (rabbit)  Thymoglobuline
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox
08.01.05 Formulary MHS England Atezolizumab Tecentriq
08.01.05 Formulary MHS England Avelumab Bavencio
08.01.05 Formulary MHS England Axitinib Inlyta
05.01.02.03 Formulary MHS England Aztreonam Lysine nebuliser solution Cayston
08.02.02 Formulary MHS England Basiliximab Simulect
08.01.01 Formulary MHS England Bendamustine Levact
08.01.05 Formulary MHS England Bortezomib Velcade
08.01.05 Formulary MHS England Bosutinib Bosulif
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris
08.01.05 Formulary MHS England Cabozantinib Cometriq, Cabometyx
05.02.04 Formulary MHS England Caspofungin Generic, Cancidas
08.01.05 Formulary MHS England Ceritinib Zykadia
05.03.02.02 Formulary MHS England Cidofovir Vistide
08.02.04 Formulary MHS England Cladribine Mavenclad
05.01.07 Formulary MHS England Colistimethate for nebulisation Colomycin, Colistin, Promixin
05.01.07 Formulary MHS England Colistimethate inhaler Colobreathe
08.01.05 Formulary MHS England Crizotinib Xalkori
08.01.05 Formulary MHS England Dabrafenib Tafinlar
05.03.03.02 Formulary MHS England Daclatasvir Daklinza
08.02.04 Non Formulary MHS England Daclizumab Zinbryta
05.03.03.02 Formulary MHS England Dasabuvir Exviera
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera
03.07 Formulary MHS England Dornase Alfa Pulmozyme
05.03.03.02 Formulary MHS England Elbasvir with Grazoprevir Zepatier
09.08.01 Restricted Use MHS England Eliglustat Cerdelga®
02.11 Restricted Use MHS England Emicizumab Hemlibra
05.03.03.01 Formulary MHS England Entecavir Generic, Baraclude
09.05.01.02 Formulary MHS England Etelcalcetide Parsabiv
08.02.04 Formulary MHS England Fingolimod Gilenya
05.03.02.02 Formulary MHS England Foscarnet Sodium Foscavir
05.03.02.02 Formulary MHS England Ganciclovir Cymevene
08.02.04 Formulary MHS England Glatiramer Acetate Copaxone
05.03.03.02 Formulary MHS England Glecaprevir with Pibrentasvir Maviret
11.99.99.99 Restricted Use MHS England Holoclar Viable autologous human corneal epithelial cells
14.05.01 Formulary MHS England Human normal immunoglobulin  
08.01.05 Formulary MHS England Ibrutinib Imbruvica
08.01.05 Formulary MHS England Idelalisib Zydelig
08.01.05 Formulary MHS England Imatinib Generic, Glivec
09.08.01 Restricted Use MHS England Imiglucerase Cerezyme
08.02.04 Formulary MHS England Interferon Beta-1a & Interferon Beta 1-b Avonex, Rebif, Extavia
08.01.05 Formulary MHS England Ipilimumab YERVOY
05.02.01 Restricted Use MHS England Isavuconazole CRESEMBA
05.03.03.01 Formulary MHS England Lamivudine Generic, Zeffix
08.03.04.03 Formulary MHS England Lanreotide Somatuline Autogel, Somatuline LA
08.02.04 Formulary MHS England Lenalidomide Revlimid
08.01.05 Formulary MHS England Lenvatinib Kisplyx, Lenvima
03.07 Formulary MHS England Mannitol  Bronchitol
03.04.02 Restricted Use MHS England Mepolizumab Nucala
05.02.04 Formulary MHS England Micafungin Mycamine
08.01.05 Formulary MHS England Midostaurin Rydapt
08.02.04 Formulary MHS England Natalizumab Tysabri
03.11 Formulary MHS England Nintedanib Ofev
08.01.05 Formulary MHS England Nintedanib  Vargatef, Ofev
01.09.01 Restricted Use MHS England Obeticholic acid Ocaliva
08.02.03 Formulary MHS England Obinutuzumab  Gazyvaro
08.03.04.03 Formulary MHS England Octreotide Sandostatin LAR
03.04.02 Formulary MHS England Omalizumab Xolair
05.03.03.02 Formulary MHS England Ombitasvir with Paritaprevir and Ritonavir Viekirax
08.01.05 Formulary MHS England Paclitaxel - Albumin Bound Formulation (Nab-paclitaxel) Abraxane
08.01.05 Formulary MHS England Palbociclib IBRANCE
08.02.04 Formulary MHS England Peginterferon beta-1a Plegridy
08.01.05 Formulary MHS England Pembrolizumab Keytruda
08.01.05 Formulary MHS England Pertuzumab Perjeta
03.11 Restricted Use MHS England Pirfenidone Esbriet
08.02.04 Formulary MHS England Pomalidomide Imnovid
05.02.01 Formulary MHS England Posaconazole Noxafil
08.01.03 Formulary MHS England Raltitrexed Tomudex
08.01.05 Formulary MHS England Regorafenib Stivarga
03.04.02 Restricted Use MHS England Reslizumab Cinqaero
05.03.03.02 Formulary MHS England Ribavirin 
08.01.05 Formulary MHS England Ribociclib Kisqali
08.02.02 Formulary MHS England Sirolimus Rapamune
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi
05.03.03.02 Formulary MHS England Sofosbuvir with ledipasvir Harvoni
05.03.03.02 Formulary MHS England Sofosbuvir with velpatasvir Epclusa
05.03.03.02 Formulary MHS England Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi
08.01.05 Formulary MHS England Sorafenib Nexavar
05.03.03.01 Formulary MHS England Tenofovir Disproxil Generic, Viread
08.02.04 Formulary MHS England Teriflunomide Aubagio
08.02.04 Formulary MHS England Thalidomide Thalidomide Celgene
08.01.05 Formulary MHS England Tivozanib Fotivda
05.01.04 Formulary MHS England Tobramycin inhaler TOBI Podhaler
05.01.04 Formulary MHS England Tobramycin nebuliser solution 
08.01.05 Formulary MHS England Trametinib Mekinist
08.01.05 Formulary MHS England Trastuzumab Ontruzant, Herceptin
08.01.05 Formulary MHS England Trastuzumab emtansine Kadcyla
05.03.02.02 Formulary MHS England Valganciclovir Valcyte, Generic
09.08.01 Restricted Use MHS England Velaglucerase alfa VPRIV
05.02.01 Formulary MHS England Voriconazole Generic, VFEND
Dorset